EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Vitamin K Prophylaxis for the Hemorrhagic Disease of the Newborns—A Short Narrative Review

Andreea Calomfirescu-Avramescu, Vlad Dima

Romanian Journal of Preventive Medicine · 2023

DOI: 10.3390/rjpm2010041 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Romanian Journal of Preventive Medicine, 2023. Verfasst von Andreea Calomfirescu-Avramescu und 1 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vitamin K deficiency bleeding (VKDB) affects 1 of 200 to 400 neonates who do not receive vitamin K prophylaxis. VKDB is classified by cause (idiopathic or secondary) and type (early, classic, late). The late type of VKDB is the least common and most severe with a mortality rate of 20%. AAP recommends that all neonates should receive a single dose of vitamin K1 soon after birth, which includes 0.5 to 1.0 mg of intramuscularly administered vitamin K1 or 1 to 2 mg of oral vitamin K1. Intramuscular administration is preferred and has more benefits than oral administration. The oral prophylaxis administration is controversial and in our Country is not available.

Zitieren

APA

Calomfirescu-Avramescu, A., & Dima, V. (2023). Vitamin K Prophylaxis for the Hemorrhagic Disease of the Newborns—A Short Narrative Review. Romanian Journal of Preventive Medicine. https://doi.org/10.3390/rjpm2010041

Vancouver

Calomfirescu-Avramescu A, Dima V. Vitamin K Prophylaxis for the Hemorrhagic Disease of the Newborns—A Short Narrative Review. Romanian Journal of Preventive Medicine. 2023. doi:10.3390/rjpm2010041

BibTeX
@article{CalomfirescuAvramescu2023,
  author = {Calomfirescu-Avramescu, Andreea and Dima, Vlad},
  title = {Vitamin K Prophylaxis for the Hemorrhagic Disease of the Newborns—A Short Narrative Review},
  journal = {Romanian Journal of Preventive Medicine},
  year = {2023},
  doi = {10.3390/rjpm2010041}
}
Kostenlos starten →